| Primary information |
|---|
| sequence ID | Seq_1222 |
| Peptide sequence | DEPPQSPWDRVK |
| CancerPDF_ID | CancerPDF_ID1588, CancerPDF_ID3581, |
| PMID | 21136997,27026199 |
| Protein Name | Apolipoprotein A-I,Apolipoprotein A-I |
| UniprotKB Entry Name | APOA1_HUMAN,APOA1_HUMAN |
| Fluid | Serum,Urine |
| M/Z | 1452.69974,NA |
| Charge | 1,NA |
| Mass (in Da) | NA,NA |
| fdr | NA,1452.66 |
| Profiling Technique | LC-MS,"CE-MS, Micro-TOF-MS" |
| Peptide Identification technique | LC-MS-MS/MS,MS-MS |
| Quantification Technique | LC-ESI-MS,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,NA |
| CancerPDF_ID | CancerPDF_ID1588, CancerPDF_ID3581, |
| p-Value | NA,less than 0.05 |
| Software | MASCOT(v. 2.2.01),Proteome Discoverer 1.2 |
| Length | 12,12 |
| Cancer Type | Colorectal cancer,Bladder cancer |
| Database | SwissProt Database,Uniprot Human non-redundant Database |
| Modification | NA,NA |
| Number of Patients | 30 patients and 30 healthy controls, 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls) |
| Regulation | NA,Differentially expressed between recurrence of UBC vs recurrence control |
| Validation | Leave One out Cross validation,Independent Validation |
| Sensitivity | NA,For testing dataset 88% |
| Specificity | NA,For testing dataset 51% |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |